Bemarituzumab
Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
FGFR
CAS Number
1952272-74-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1374746-01 0.02 mg (E-Coli)
Recombinant Burkholderia thailandensis Cytidylate kinase (cmk)
Ask
View Details MBS1374746-02 0.1 mg (E-Coli)
Recombinant Burkholderia thailandensis Cytidylate kinase (cmk)
Ask
View Details 
MBS1374746-03 0.02 mg (Yeast)
Recombinant Burkholderia thailandensis Cytidylate kinase (cmk)
Ask
View Details MBS1374746-04 0.1 mg (Yeast)
Recombinant Burkholderia thailandensis Cytidylate kinase (cmk)
Ask
View Details MBS1374746-05 0.02 mg (Baculovirus)
Recombinant Burkholderia thailandensis Cytidylate kinase (cmk)
Ask
View Details 
MBS1374746-06 0.02 mg (Mammalian-Cell)
Recombinant Burkholderia thailandensis Cytidylate kinase (cmk)
Ask
View Details